Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insights
Heming Li, Izhar Singh Batth, Xiujuan Qu, et al.
Molecular Cancer (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

EGFR-TKIs resistance via EGFR-independent signaling pathways
Qian Liu, Shengnan Yu, Weiheng Zhao, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 303
Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy
Hui Hua, Qingbin Kong, Jie Yin, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 201
EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies
Xuan Zhu, Lijie Chen, Ling Liu, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 173
Epithelial-to-mesenchymal transition in tumor progression
Elena Prieto‐García, C. Vanesa Díaz-García, Inmaculada García‐Ruíz, et al.
Medical Oncology (2017) Vol. 34, Iss. 7
Closed Access | Times Cited: 127
Chemotherapy resistance mechanisms in advanced skin cancer
Bhuvanesh Sukhlal Kalal, Dinesh Upadhya, Vinitha Ramanath Pai
Oncology Reviews (2017)
Open Access | Times Cited: 122
Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk
Jin Li, Fan Shen, Michael Weinfeld, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 97
Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target
Wenjing Qian, Mingfang Zhao, Ruoyu Wang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 78
Receptor Tyrosine Kinases in Osteosarcoma Treatment: Which Is the Key Target?
Zhichao Tian, Xiaohui Niu, Weitao Yao
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 70
The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions
Ayda Baghery Saghchy Khorasani, Atieh Pourbagheri‐Sigaroodi, Ali Pirsalehi, et al.
European Journal of Pharmacology (2021) Vol. 898, pp. 173983-173983
Closed Access | Times Cited: 64
Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy
Veronica Vella, Rosamaria Lappano, Eduardo Bonavita, et al.
Endocrine Reviews (2023) Vol. 44, Iss. 4, pp. 693-723
Open Access | Times Cited: 27
Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric Cancer
Heming Li, Yangzhuangzhuang Zhu, Lu Xu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 8
Insulin-Like Growth Factor-1 Signaling in Lung Development and Inflammatory Lung Diseases
Zheng Wang, Wenting Li, Qiongya Guo, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-27
Open Access | Times Cited: 82
Molecular Signatures of the Insulin-Like Growth Factor 1-Mediated Epithelial-Mesenchymal Transition in Breast, Lung and Gastric Cancers
Armando Cevenini, Stefania Orrù, Annamaria Mancini, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 8, pp. 2411-2411
Open Access | Times Cited: 82
PVT1 Long Non-coding RNA in Gastrointestinal Cancer
Águeda Martínez‐Barriocanal, Diego Arango, Higinio Dopeso
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 58
Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer
Arthur Dondi, Ulrike Lischetti, Francis Jacob, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Protein restriction and cancer
Jie Yin, Wenkai Ren, Xingguo Huang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2018) Vol. 1869, Iss. 2, pp. 256-262
Closed Access | Times Cited: 58
The role of liver microenvironment in hepatic metastasis
Tovah Williamson, Nikhila Sultanpuram, Hossein Sendi
Clinical and Translational Medicine (2019) Vol. 8, Iss. 1
Open Access | Times Cited: 51
IGF-1R targeting in cancer – does sub-cellular localization matter?
Upendra Kumar Soni, Liam Jenny, Rashmi S. Hegde
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 15
Metformin and HER2-positive breast cancer: Mechanisms and therapeutic implications
Sara S. Bashraheel, Hadeel Kheraldine, Sarah Khalaf, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114676-114676
Open Access | Times Cited: 14
Picropodophyllotoxin alters EMT in neuroblastoma via inhibition of surface receptors IFG1R and ALK
Poonam Bhagriya, Afridi Shaikh, Hetal Roy
Growth Hormone & IGF Research (2025) Vol. 80, pp. 101638-101638
Closed Access
Picropodophyllin, an IGF‑1 receptor inhibitor, enhances oxaliplatin efficacy in chemoresistant colorectal cancer HCT116 cells by reducing metastatic potential
Nurçin Kayacık, Hasan Kurter, Tolga Sever, et al.
Oncology Letters (2025) Vol. 29, Iss. 5, pp. 1-12
Open Access
Size-Dependent Pulmonary Toxicity and Whole-Body Distribution of Inhaled Micro/Nanoplastic Particles in Male Mice from Chronic Exposure
Leijian Chen, Yu Liu, Huankai Li, et al.
Environmental Science & Technology (2025)
Closed Access
Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer
Chenxi Zhao, Chenming Zeng, Song Ye, et al.
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 6, pp. 947-960
Open Access | Times Cited: 41
IGF-1 reverses the osteogenic inhibitory effect of dexamethasone on BMP9-induced osteogenic differentiation in mouse embryonic fibroblasts via PI3K/AKT/COX-2 pathway
Haitao Jiang, Cheng-Cheng Ran, Yun‐Peng Liao, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2019) Vol. 191, pp. 105363-105363
Closed Access | Times Cited: 37
Unresolved Complexity in the Gene Regulatory Network Underlying EMT
Deborah Lavin, Vijay Tiwari
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top